Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Kornprat, P; Pollheimer, MJ; Lindtner, RA; Schlemmer, A; Rehak, P; Langner, C.
Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal.
Am J Clin Oncol. 2011; 34(1):43-49
Doi: 10.1097/COC.0b013e3181cae8dd
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Kornprat Peter
- Langner Cord
- Co-Autor*innen der Med Uni Graz
- Pollheimer Marion
- Rehak Peter
- Schlemmer Andrea
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Vertical tumor growth, reflected by T classification, represents the most important prognostic variable in colorectal cancer. Our study aimed to investigate the impact of tumor size, particularly the maximum tumor diameter, on outcome of affected patients. A total of 381 colorectal cancer specimens were re-evaluated. Tumor size and location were extracted from the medical history and were known for 359 patients (94%). Receiver-operator characteristic analysis was applied to identify the optimal (maximum of sum of sensitivity and specificity) cut-off values with respect to prognostic impact. Median tumor size was 4.5 cm (range, 0.6-15). Tumor size exceeding 4.5 cm was observed in 159 patients (44%) and was associated with high T and N classification, UICC stage, and tumor grade. At median follow-up of 45 months (range, 0-180), 141 patients (40%) showed tumor progression. Although 4.5 cm was identified as the optimal cut-off value within the whole group of patients, receiver-operator characteristic analysis restricted to different parts of the large bowel determined 5 cm, 5.3 cm, 3.9 cm, and 3.4 cm as cut-off values with the strongest discriminatory capacity in colon, right-sided colon, left-sided colon, and rectum cancers, respectively. Applying these cut-off values, tumor size was significantly associated with progression-free and cancer-specific survival in univariate and multivariate analyses in colon, yet not in rectum cancers. Tumor size proved to be an independent prognostic parameter for patients with colorectal cancer. Optimal cut-off values vary among different parts of the large bowel. Whereas prognostic significance is strong within the colon, it appears to be of minor value within the rectum.
- Find related publications in this database (using NLM MeSH Indexing)
- Antineoplastic Agents - therapeutic use
- Biomarkers, Tumor - analysis
- Chemotherapy, Adjuvant -
- Colorectal Neoplasms - chemistry Colorectal Neoplasms - pathology Colorectal Neoplasms - therapy
- Female -
- Follow-Up Studies -
- Humans -
- Male -
- Neoplasm Staging -
- Prognosis -
- ROC Curve -
- Radiotherapy, Adjuvant -
- Sensitivity and Specificity -
- Survival Rate -
- Find related publications in this database (Keywords)
- colorectal cancer
- tumor size
- tumor diameter
- progression-free survival
- cancer-specific survival
- multivariate analysis